Cargando…
Impact of epigenetic reprogramming on antitumor immune responses in glioma
Epigenetic remodeling is a molecular hallmark of gliomas, and it has been identified as a key mediator of glioma progression. Epigenetic dysregulation contributes to gliomagenesis, tumor progression, and responses to immunotherapies, as well as determining clinical features. This epigenetic remodeli...
Autores principales: | McClellan, Brandon L., Haase, Santiago, Nunez, Felipe J., Alghamri, Mahmoud S., Dabaja, Ali A., Lowenstein, Pedro R., Castro, Maria G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843056/ https://www.ncbi.nlm.nih.gov/pubmed/36647827 http://dx.doi.org/10.1172/JCI163450 |
Ejemplares similares
-
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Pediatric High-Grade Gliomas
por: Garcia-Fabiani, Maria B., et al.
Publicado: (2023) -
Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies
por: Garcia-Fabiani, Maria B., et al.
Publicado: (2021) -
Current Approaches for Glioma Gene Therapy and Virotherapy
por: Banerjee, Kaushik, et al.
Publicado: (2021) -
Murine brain tumor microenvironment immunophenotyping using mass cytometry
por: McClellan, Brandon L., et al.
Publicado: (2022) -
Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
por: Alghamri, Mahmoud S., et al.
Publicado: (2021)